A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
出版年份 2020 全文链接
标题
A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 21, Pages 4930
出版商
MDPI AG
发表日期
2020-10-26
DOI
10.3390/molecules25214930
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation
- (2020) James M. Nichols et al. Journal of Neuroimmune Pharmacology
- The Cuprizone Model: Dos and Do Nots
- (2020) Jiangshan Zhan et al. Cells
- Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors
- (2020) Yi Yang et al. MOLECULES
- Phytocannabinoids: Origins and Biosynthesis
- (2020) Thies Gülck et al. TRENDS IN PLANT SCIENCE
- Conversion of cannabidiol (CBD) to Δ9-tetrahydrocannabinol (Δ9-THC) during protein precipitations prior to plasma samples analysis by chromatography – Troubles with reliable CBD quantitation when acidic precipitation agents are applied
- (2020) Michal P. Dybowski et al. TALANTA
- Facets of Theiler’s Murine Encephalomyelitis Virus-Induced Diseases: An Update
- (2019) Ingo Gerhauser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
- (2019) Raquel Guerrero-Alba et al. Frontiers in Pharmacology
- Complete biosynthesis of cannabinoids and their unnatural analogues in yeast
- (2019) Xiaozhou Luo et al. NATURE
- Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol
- (2019) Samuel D. Banister et al. ACS Chemical Neuroscience
- Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis
- (2019) Anthony Feinstein et al. BRAIN
- Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
- (2019) Zinah Z. Al-Ghezi et al. BRAIN BEHAVIOR AND IMMUNITY
- Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis
- (2019) Ting Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
- (2019) Zinah Zamil Al-Ghezi et al. Frontiers in Immunology
- Cannabinoids and the expanded endocannabinoid system in neurological disorders
- (2019) Luigia Cristino et al. Nature Reviews Neurology
- Cannabinoids for Treatment of MS Symptoms: State of the Evidence
- (2018) Jessica Rice et al. Current Neurology and Neuroscience Reports
- Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
- (2018) Jolana Markovà et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Biochemically altered myelin triggers autoimmune demyelination
- (2018) Andrew V. Caprariello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
- (2018) Andrea Manterola et al. BIOCHEMICAL PHARMACOLOGY
- Therapeutic applications of cannabinoids
- (2018) Nancy Maurya et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Inhibitory effects of cannabidiol on voltage-dependent sodium currents
- (2018) Mohammad-Reza Ghovanloo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabinoid Delivery Systems for Pain and Inflammation Treatment
- (2018) Natascia Bruni et al. MOLECULES
- Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
- (2018) David M. Elliott et al. Frontiers in Immunology
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients
- (2017) Sebastian Schimrigk et al. EUROPEAN NEUROLOGY
- Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis
- (2017) Coral González-García et al. EXPERIMENTAL NEUROLOGY
- Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis
- (2017) John-Mark K. Fitzpatrick et al. NEUROPHARMACOLOGY
- Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis
- (2017) Guido van Amerongen et al. CLINICAL THERAPEUTICS
- Evaluating Sativex®in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis
- (2016) Margherita Russo et al. PAIN MEDICINE
- Medicinal chemistry of cannabinoids
- (2015) V Kiran Vemuri et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis
- (2015) Letizia Leocani et al. JOURNAL OF NEUROLOGY
- Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study
- (2015) Laura Ferrè et al. NEUROLOGICAL SCIENCES
- Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice
- (2015) A. Rahimi et al. NEUROSCIENCE
- The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors
- (2015) Miguel Moreno-Martet et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis, cannabis, and cognition: A structural MRI study
- (2015) Kristoffer Romero et al. NeuroImage-Clinical
- Revised diagnostic criteria of multiple sclerosis
- (2014) Ron Milo et al. AUTOIMMUNITY REVIEWS
- Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
- (2014) S. Vlachou et al. CURRENT PHARMACEUTICAL DESIGN
- Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity
- (2014) Jürgen Koehler et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Effects of cannabis on cognition in patients with MS: A psychometric and MRI study
- (2014) B. Pavisian et al. NEUROLOGY
- Immunomodulatory activity of interferon-beta
- (2014) Lloyd H. Kasper et al. Annals of Clinical and Translational Neurology
- Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future
- (2014) George Panagis et al. Frontiers in Psychiatry
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- Extent of illicit drug use and dependence, and their contribution to the global burden of disease
- (2012) Louisa Degenhardt et al. LANCET
- Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
- (2012) R. G. Pertwee PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids: Occurrence and Medicinal Chemistry
- (2011) G. Appendino et al. CURRENT MEDICINAL CHEMISTRY
- Effects of cannabis on cognitive function in patients with multiple sclerosis
- (2011) K. Honarmand et al. NEUROLOGY
- The impact of early-onset cannabis use on functional brain correlates of working memory
- (2010) Benjamin Becker et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The cuprizone animal model: new insights into an old story
- (2009) Markus Kipp et al. ACTA NEUROPATHOLOGICA
- An introduction to the endocannabinoid system: from the early to the latest concepts
- (2009) Luciano De Petrocellis et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis
- (2008) Massimiliano Aragona et al. CLINICAL NEUROPHARMACOLOGY
- Acute hemorrhagic demyelination in a murine model of multiple sclerosis
- (2008) Istvan Pirko et al. Journal of Neuroinflammation
- Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8
- (2008) L. De Petrocellis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now